What is the ticker symbol for Arvinas?

Arvinas trades under the ticker ARVN on NASDAQ.

What sector does Arvinas operate in?

Arvinas is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ARVN in a portfolio?

PortView shows ARVN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Arvinas (ARVN) Stock Analysis

NASDAQHealthcareBiotechnology

$9.34+0.59%

1-year price historyRange $6.98 – $13.83

52-week range$9.34

$6.97$14.51

What Arvinas does

Arvinas, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to identifying, advancing, and marketing innovative therapies designed to eliminate disease-causing proteins. The company's pipeline features several promising candidates. These include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader, currently in Phase I clinical trials, which specifically targets the androgen receptor (AR) protein to treat metastatic castration-resistant prostate cancer (mCRPC) in men. Another key PROTAC protein degrader is ARV-471, which targets the estrogen receptor protein for patients suffering from metastatic ER-positive/HER2-negative breast cancer. Furthermore, Arvinas is developing ARV-766, an investigational orally bioavailable PROTAC protein degrader also aimed at treating mCRPC in men. The company has strategic alliances with major pharmaceutical entities including Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Founded in 2013, Arvinas, Inc. is headquartered in New Haven, Connecticut.

Key metrics

Market cap

$602.31M

P/E (TTM)

93.35

EPS (TTM)

$0.10

Beta

1.74

Dividend yield

0.00%

Revenue / share

$4.89

50-day avg

$8.59

200-day avg

$10.56

52-week high

$14.51

52-week low

$6.97

CEO

Randy Teel

ETFs linked to ARVN

Broad-market and Healthcare sector ETFs an investor holding Arvinas is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ARVN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ARVN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Arvinas?: Arvinas trades under the ticker ARVN on NASDAQ.
Which exchange is ARVN listed on?: ARVN is listed on NASDAQ.
What sector does Arvinas operate in?: Arvinas is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ARVN in a portfolio?: PortView shows ARVN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.